Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. NRX Pharmaceuticals ( (NRXP)) has shared ...

HOPE Therapeutics and a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP) announced signing of a Binding Term Sheet with Smith & Sauer, LLC, for $25 million equity purchases to fund planned HOPE ...

NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025.

NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) shares are moving higher on Tuesday after it oversaw an investment of $27 million in its subsidiary HOPE Therapeutics. The Details: The purpose of the ...

WILMINGTON, Del., April 21, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage ...

MIAMI, April 30, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc., (Nasdaq:NRXP or "the Company"), today announced the grant of a filing fee waiver by the US Food and Drug Administration ("FDA") to ...

NRx Pharmaceuticals (NASDAQ:NRXP) stock rallied 35% Monday after its subsidiary HOPE Therapeutics announced the signing of a binding term sheet with Smith & Sauer for $25M in equity purchases to fund ...

WILMINGTON, Del., Aug. 4, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced the filing of a Citizen Petition with the US Food ...

Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamine Granting of Suitability Petition ...